miR-1246 Enhances Chemo-Resistance of Polyploid Giant Cancer Cells in H1299 Cells by Targeting GSK3b/b-catenin

Strategic Insights -

Research conducted at the General Hospital of Northern Theatre Command has shed light on the role of miR-1246 in the development of chemo-resistance in non-small cell lung cancer (NSCLC). The study found that miR-1246 levels were significantly higher in polyploid giant cancer cells (PGCCs) than in the original cells, leading to enhanced chemo-resistance, apoptosis, migration, and epithelial-mesenchymal transition. The research suggests that NSCLC H1299 cells may employ polyploidy formation as a survival mechanism in response to docetaxel-based treatment, mediated by the miR-1246/GSK3b/b-catenin axis.

Key Takeaways:

  • The study revealed that miR-1246 levels were significantly higher in PGCCs than in the original cells, affecting chemo-resistance, apoptosis, migration, and epithelial-mesenchymal transition.
  • The research found that miR-1246 played a crucial role in the development of chemo-resistance in NSCLC H1299 cells.
  • The study suggested that the miR-1246/GSK3b/b-catenin axis may be a key regulatory mechanism in the development of chemo-resistance.
  • Polyploidy formation was observed as a survival mechanism in response to docetaxel-based treatment in NSCLC H1299 cells.
  • The dysregulated expression of miR-1246 has been implicated in the modulation of gene expression related to drug resistance.
  • H1299 cells were treated with 100 nM docetaxel for 24 h, and then allowed to recover for 3 days to form PGCCs.
  • The miR-1246 profiles of these PGCCs were analyzed, focusing on miR-1246, and transfection with miR-1246 mimics or inhibitors was performed.
  • Various assays were used to assess the effects of miR-1246 in PGCCs.
  • The study found that miR-1246 levels were significantly higher in PGCCs than in the original cells, affecting chemo-resistance, apoptosis, migration, and epithelial-mesenchymal transition.

Statistics:

  • 100 nM docetaxel was used to treat H1299 cells for 24 h.
  • 3 days were allowed for the cells to recover and form PGCCs.
  • 1 study found miR-1246 levels were significantly higher in PGCCs than in the original cells.
  • 13 pages were included in the study, published in Discover Oncology, 2025,16(1):1-13.

Sources:

  • Discover Oncology, 2025,16(1):1-13. The publisher for Discover Oncology is Springer.
  • https://doi-org.sdpl.idm.oclc.org/10.1007/s12672-025-02756-0. A free version of this journal article is available.
  • Cancer Weekly, June 10, 2025; p 1117. The citation for this news report is: NewsRx. Recent Studies from General Hospital of Northern Theatre Command Add New Data to Cancer (miR-1246 enhances chemo-resistance of polyploid giant cancer cells in H1299 cells by targeting GSK3b/b-catenin).